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Figure S-1. Structure of compound syn-1 in the solid state. 
CCDC 1038629 contains the supporting crystallographic data for this paper. These data can 
be obtained free of charge from the Cambridge Crystallographic Data Centre via 
www.ccdc.cam.ac.uk/data_request/cif. 
X-ray Crystal Structure Analysis of compound 1: C24 H29 Br2 N O3, Mr = 539.30 g · mol
-1
,
colorless plate, crystal size 0.25 x 0.07 x 0.05 mm, orthorhombic, space group P212121, a = 
4.7865(4) Å, b = 20.3783(16) Å, c = 24.3411(19) Å, V = 2374.2(3) Å
3
, T = 100 K, Z = 4, Dcalc
= 1.509 g · cm
3
,  = 1.54178 Å, (Cu-K) = 4.525 mm-1; empirical absorption correction
(Tmin = 0.25, Tmax = 0.84), Bruker AXS X8 Proteum diffractometer, 2.828 <  < 67.738°, 
63947 measured reflections, 4285 independent reflections, 4199 reflections with I > 2(I), 




 to R1 =
0.033 [I > 2(I)], wR2 = 0.089, 273 parameters, absolute structure parameter = 0.009(7), H 
































General. All reactions were carried out under Ar in flame-dried glassware. The solvents were 
purified by distillation over the indicated drying agents and were transferred under Ar: THF, 
Et2O (Mg/anthracene), CH2Cl2, MeCN (CaH2), hexane, toluene (Na/K), MeOH (Mg), DMF 
(MS 4 Å). Flash chromatography: Merck silica gel 60 (40–63 μm) or Florisil (60-100 mesh). 
NMR: Spectra were recorded on a Bruker DPX 300, AV 400, AV 500 or AVIII 600 
spectrometer in the solvents indicated; chemical shifts (δ) are given in ppm relative to TMS, 
coupling constants (J) in Hz. The solvent signals were used as references and the chemical 
shifts converted to the TMS scale (CDCl3: δC 77.2 ppm; residual CHCl3 in CDCl3: 
δH 7.26 ppm; C6D6: δC128.1 ppm; residual C6D5H: δH7.16 ppm). Where indicated, the 
signal assignments are unambiguous; the numbering scheme is arbitrary and shown in the 
inserts. The assignments are based upon 1D and 2D spectra recorded using the following 
pulse sequences from the Bruker standard pulse program library: DEPT; COSY (cosygpqf and 
cosydqtp); HSQC (hsqcedetgpsisp2.2) optimized for 
1
JC,H = 145 Hz; HMBC (hmbcetgpl3nd) 
for correlations via 
n
JC,H; HSQC-TOCSY (invietgsml) using an MLEV17 mixing time of 
120 ms; NOESY (noesygpph). IR: Spectrum One (Perkin-Elmer) spectrometer, wavenumbers 
(?̃?) in cm1. MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ3000 (Bruker), accurate 
mass determinations: Bruker APEX III FT-MS (7 T magnet) or Mat 95 (Finnigan). Unless 
stated otherwise, all commercial compounds (Fluka, Acros, Aldrich) were used as received. 
Compound 8. A suspension of powdered MS 4 Å (2.00 g) in CH2Cl2 (60 mL) was stirred      
–35 °C for 10 min before titanium tetraisopropoxide (1.76 mL, 5.94 mmol, 
10 mol%) and (+)-diisopropyl L-tartrate (1.62 mL, 7.73 mmol, 0.13 equiv) were 
added. Stirring was continued for 3 h at –35 °C before 1,4-pentadien-3-ol (5.78 mL, 59.4 
mmol) was slowly introduced, followed by cumene hydroperoxide (17.6 mL, 119 mmol). The 
mixture was stirred for 38 h at –35 °C before the reaction was quenched with saturated 
aqueous Na2SO4 (5 mL). The mixture was diluted with tert-butyl methyl ether (50 mL) and 
the suspension was stirred for 3 h before the resulting slurry was filtered through a pad of 
Celite. The filtrate was concentrated and excess 2-phenyl-2-propanol and cumene hydro-
peroxide were removed by flash chromatography (SiO2, hexanes/tert-butyl methyl 
ether = 5:1) to give the desired epoxide as a colorless oil (4.87 g, 82%). 
25
D][  = +68.8 
(c = 0.73, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 5.83 (ddd, 1H, J = 17.2, 10.5, 6.2 Hz), 
5.38 (dt, 1H, J = 17.2, 1.3 Hz), 5.25 (dt, 1H, J = 10.5, 1.3 Hz), 4.34 – 4.28 (m, 1H), 3.08 (dt, 
1H, J = 4.0, 3.0 Hz), 2.79 (dd, 1H, J = 5.0, 3.0 Hz), 2.74 (dd, 1H, J = 5.0, 4.0 Hz), 2.23 ppm 
(d, 1H, J = 3.0 Hz); 
13
C NMR (100 MHz, CDCl3):  = 135.6, 117.7, 70.3, 54.0, 43.6 ppm; IR 
(film): ~  = 3417, 2997, 1427, 1251, 1024, 972, 930, 885, 832, 793, 756 cm−1; MS (EI): m/z 
(%) 69 (22), 57 (100), 55 (24), 43 (29), 31 (18), 29 (55), 27 (29); HRMS (CI): m/z: calcd. for 
C5H9O2 [M+H
+
]: 101.0603, found: 101.0602. The spectral data are in good agreement with 
those previously reported in the literature.
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Compound S1. TBSCl (6.96 g, 46.2 mmol) was added at 0 °C to a solution of compound 8 
(4.20 g, 42.0 mmol) and imidazole (6.00 g, 88.2 mmol) in DMF (42 mL). After 
stirring for 1 h at 0 °C, the mixture was diluted with tert-butyl methyl ether (300 
mL) and washed with water (4  100 mL) and brine (1  100 mL). The organic 
phase was dried over Na2SO4 and concentrated, and the residue was purified by flash 
chromatography (SiO2, hexanes/tert-butyl methyl ether = 10:1) to give the title compound as a 
colorless oil (8.09 g, 90%). 
25
D][  = +1.90 (c = 0.73, CHCl3); 
1
H NMR (400 MHz, CDCl3): 
 = 5.88 (ddd, 1H, J = 17.2, 10.4, 5.5 Hz), 5.32 (dt, 1H, J = 17.2, 1.5 Hz), 5.18 (dt, 1H, 
J = 10.4, 1.5 Hz), 4.12 (ddt, 1H, J = 5.5, 4.0, 1.5 Hz), 2.94 (td, 1H, J = 3.9, 3.1 Hz), 2.70 – 
2.69 m, 2H), 0.89 (s, 9H), 0.06 (s, 3H), 0.05 ppm (s, 3H); 
13
C NMR (100 MHz, CDCl3): 
 = 137.6, 116.0, 72.6, 54.6, 44.4, 25.9 (3C), 18.4, −4.6, −4.7 ppm; IR (film): ~  = 2956, 
2930, 2857, 1472, 1250, 1119, 1079, 1033, 1000, 926, 834, 774, 673 cm
−1
; MS (EI): m/z (%) 
171 (11), 157 (18), 127 (100), 101 (32), 75 (71), 59 (23), 45 (13); HRMS (ESI+): m/z: calcd. 
for C11H22NaO2Si [M+Na
+
]: 237.1281, found: 237.1283. 
Compound 9. A mixture of compound S1 (8.00 g, 37.3 mmol) and palladium on charcoal 
(10% Pd, 400 mg) in EtOAc (80 mL) was vigorously stirred under H2 atmosphere 
for 2 h. The suspension was filtered through a pad of Celite and the filtrate was 
concentrated. The residue was distilled in a Kugelrohr apparatus (90–105 C, 9 mbar) to give 
the title compound as a colorless oil (7.65 g, 95%). 
25
D][  = +13.0 (c = 0.73, CHCl3); 
1
H NMR 
(400 MHz, CDCl3):  = 3.51 (dt, 1H, J = 6.6 Hz), 2.86 (ddd, 1H, J = 4.6, 3.9, 2.6 Hz), 2.69 
(dd, 1H, J = 5.5, 3.9 Hz), 2.65 (dd, 1H, J = 5.0, 2.6 Hz), 1.71 – 1.49 (m, 2H), 0.96 (t, 3H, 
J = 7.5 Hz), 0.88 (s, 9H), 0.04 (s, 3H), 0.04 ppm (s, 3H); 
13
C NMR (100 MHz, CDCl3):  = 
72.5, 54.6, 44.9, 28.3, 26.0 (3C), 18.3, 9.4, −4.3, −4.7 ppm; IR (film): ~ = 2957, 2930, 2857, 
1463, 1251, 1110, 1074, 1017, 994, 833, 773 cm
−1
; MS (EI): m/z (%)173 (4), 159 (29), 129 
(44), 117 (33), 101 (48), 89 (11), 75 (100), 59 (22); HRMS (ESI+): m/z: calcd. for 
C11H24NaO2Si [M+Na
+
]: 239.1438, found: 239.1438. The 
1
H NMR data are in good 
agreement with those previously reported in the literature.
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Compound S2. A solution of propargyl alcohol (30.0 mL, 515 mmol) and p-TsOH·H2O (98.0 
mg, 0.515 mmol, 0.10 mol%) in ethyl vinyl ether (74 mL) was stirred for 5 h 
at 0 C. The reaction was quenched with saturated aqueous Na2CO3 (10 mL). 
Excess Na2CO3 was then added before the mixture was passed through a glass filter. 
Evaporation of the filtrate followed by distillation of the residue in a Vigreux column (bp 58 – 
64 C, 50 mbar) gave the title compound as a colorless oil (55.6 g, 84%). 1H NMR (400 MHz, 
CDCl3):  = 4.85 (q, 1H, J = 5.4 Hz), 4.20 (d, 2H, J = 2.4 Hz), 3.65 (dq, 2H, J = 9.4, 7.1 Hz), 
3.51 (dq, 1H, J = 9.4, 7.1 Hz), 2.39 (t, 1H, J = 2.4 Hz), 1.33 (d, 3H, J = 5.4 Hz), 1.20 ppm (t, 
3H, J = 7.1 Hz); 
13
C NMR (100 MHz, CDCl3):  = 98.8, 80.2, 73.9, 60.9, 52.6, 19.8, 
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15.4 ppm; IR (film): ~  = 2979, 2933, 2900, 1445, 1385, 1339, 1267, 1128, 1084, 1052, 1036, 
991, 946, 927, 852, 823, 659, 631, 500 cm
−1
; MS (EI): m/z (%) 113 (87), 85 (29), 83 (95), 73 
(100), 57 (31), 55 (33), 45 (99), 43 (94),39 (95), 29 (61); HRMS (CI): m/z: calcd. for C7H13O2 
[M+H
+
]: 129.0916, found: 129.0915. The NMR data are in good agreement with those 
previously reported in the literature.
3,4
 
Compound 11. EtMgBr (3.0 M in Et2O, 39.6 mL, 119 mmol) was diluted with THF (120 mL) 
and the solution warmed to 45 C. 3-(1-Ethoxyethoxy)prop-1-yne S2 
(15.0 mL, 110 mmol) was added dropwise at this temperature. After 
stirring for 0.5 h, CuCl (546 mg, 5.51 mmol, 5 mol%) was introduced and the mixture stirred 
at 50 °C for 0.5 h. A toluene solution of propargyl bromide (80%, 14.1 mL, 127 mmol) was 
then added dropwise, the temperature was raised to 60 °C and stirring continued for 1.5 h. For 
work up, the mixture was cooled to ambient temperature and then poured into a solution of 
KCN (1.94 g) and NH4Cl (14.8 g) in water (97.8 mL). The aqueous phase was extracted with 
tert-butyl methyl ether (3 x), and the combined extracts were washed with water and brine, 
dried over Na2SO4, and concentrated. The residue was purified by distillation (bp 53 – 55 C, 
0.07 mbar) to give the title compound as a pale yellow oil (12.4 g, 68%). This product is very 
sensitive to air and must be stored under argon in a freezer. 
1
H NMR (400 MHz, CDCl3):  = 
4.82 (q, 1H, J = 5.4 Hz), 4.18 (dt, 2H, J = 2.2, 1.1 Hz), 3.64 (dq, 1H, J = 9.4, 7.1 Hz), 3.50 
(dq, 1H, J = 9.4, 7.1 Hz), 3.21 – 3.18 (m, 2H), 2.05 (t, 1H, J = 2.8 Hz), 1.31 (d, 3H, J = 
5.4 Hz), 1.19 ppm (t, 3H, J = 7.1 Hz); 
13
C NMR (100 MHz, CDCl3):  = 98.7, 79.2, 77.9, 
77.2, 69.1, 60.8, 53.1, 19.8, 15.4, 9.8 ppm; IR (film): ~  = 3295, 2979, 2900, 1445, 1385, 
1338, 1311, 1124, 1083, 1053, 1028, 979, 945, 927, 854 cm
−1
; MS (EI): m/z (%) 151 (20), 
121 (25), 93 (10), 77 (100), 73 (53), 65 (7), 51 (39), 45 (57); HRMS (CI): m/z: calcd. for 
C10H15O2 [M+H
+
]: 167.1072, found: 167.1073. 
Compound 12. n-BuLi (1.6 M in hexanes, 2.60 mL, 4.16 mmol) was added dropwise to a 
solution of the skipped diyne 11 (691 mg, 4.16 mmol) in THF 
(40 mL) at –78 C. After stirring for 0.5 h at that temperature, 
BF3·OEt2 (513 L, 4.16 mmol) was slowly introduced. After 
stirring for 5 min, a solution of the epoxide 9 (300 mg, 1.39 mmol) in THF (4 mL) was added 
and stirring continued for 0.5 h at –78 C. For work up, the solution was poured into saturated 
aqueous NaHCO3 (40 mL) and the mixture extracted with tert-butyl methyl ether (3 x). The 
combined extracts were washed with water and brine, dried over Na2SO4, and concentrated, 
and the crude product was purified by flash chromatography (SiO2, hexane/EtOAc = 10:1 
containing 1% Et3N) to give the title compound as a yellow oil (381 mg, 72%). 
25
D][ = +16.4 
(c = 1.55, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 4.82 (q, 1H, J = 5.3 Hz), 4.18 (q, 2H, J = 
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2.2 Hz), 3.73 – 3.59 (m, 3H), 3.50 (dq, 1H, J = 9.4, 7.1 Hz), 3.19 (tt, 2H, J = 2.2, 2.2 Hz), 
2.40 – 2.35 (m, 2H), 2.17 (br s, 1H), 1.63 – 1.40 (m, 2H), 1.32 (d, 3H, J = 5.3 Hz), 1.19 (t, 
3H, J = 7.1 Hz), 0.90 (t, 3H, J = 7.4 Hz), 0.89 (s, 9H), 0.07 (s, 3H), 0.07 ppm (s, 3H); 
13
C NMR (100 MHz, CDCl3):  = 98.7, 80.3, 76.6, 75.9, 75.2, 72.1, 60.7, 53.1, 46.3, 26.0 
(3C), 24.7, 22.8, 19.8, 18.2, 15.4, 10.1, 9.4, −4.3, −4.4 ppm; IR (film): ~  = 3481, 2930, 2858, 
1463, 1384, 1253, 1128, 1084, 1055, 1030, 1004, 928, 834, 774, 668 cm
−1
; MS (EI): m/z 
(%)279 (13), 235 (21), 173 (61), 145 (24), 115 (9), 91 (7), 73 (100), 45 (26); HRMS (ESI+): 
m/z: calcd. for C21H38NaO4Si [M+Na
+
]: 405.2432, found: 405.2428.  
Compound S3. A solution of compound 12 (775 mg, 2.03 mmol) and pyridinium p-
toluenesulfonate (509 mg, 2.03 mmol) in MeOH (100 mL) was 
stirred for 1 h at ambient temperature before saturated aqueous 
NaHCO3 was added. The mixture was concentrated to remove the 
MeOH prior to extraction with EtOAc (3 x). The combined extracts were washed with water 
and brine, dried over Na2SO4, and concentrated. The crude product was purified by flash 
chromatography (SiO2, hexane/EtOAc = 2:1 containing 1% Et3N) to give the title compound 
as a yellow oil (615 mg, 98%). 
1
H NMR (400 MHz, CDCl3):  = 4.25 (t, 2H, J = 2.2 Hz), 3.74 
– 3.64 (m, 2H), 3.20 (tt, 2H, J = 2.3, 2.3 Hz), 2.41 – 2.36 (m, 2H), 1.64 – 1.39 (m, 2H), 0.91 
(t, 3H, J = 7.5 Hz), 0.89 (s, 9H), 0.08 (s, 3H), 0.08 ppm (s, 3H); 
13
C NMR (100 MHz, CDCl3): 
 = 80.5, 78.7, 77.6, 75.8, 75.2, 72.2, 51.4, 26.0 (3C), 24.6, 22.8, 18.2, 10.1, 9.5, −4.3, 
−4.4 ppm; IR (film): ~  = 3361, 2929, 2857, 1463, 1252, 1068, 1003, 834, 773, 668 cm−1; MS 
(EI): m/z (%): 235 (21), 187 (11), 174 (14), 173 (100), 145 (53), 133 (14), 117 (19), 115 (27), 
105 (13), 91 (16), 77 (12), 75 (98), 73 (82), 57 (23); HRMS (ESI+): m/z: calcd. for 
C17H30O3SiNa [M+Na
+
]: 333.1854, found: 333.1856.  
Compound S4. A solution of NaBH4 (1 M in EtOH, 495 L, 0.495 mmol, 25 mol%) was 
added to a solution of Ni(OAc)2·4H2O (138 mg, 0.495 mmol, 25 mol%) 
in EtOH (0.7 mL). After the evolution of hydrogen had ceased, the 
resulting black suspension was cooled to –78 C and the flask was filled 
with hydrogen gas. 1,2-Ethylenediamine (106 L, 1.58 mmol) and a solution of the skipped 
diyne S3 (615 mg, 1.98 mmol) were added and the mixture was allowed to reach ambient 
temperature. After stirring for 7 h, the mixture was diluted with EtOAc. The resulting 
suspension was filtered through a pad of Celite and the filtrate was concentrated. The residue 
was purified by flash chromatography (SiO2, hexane/EtOAc = 3:1 containing 1% Et3N) to 




D][ = +2.2 (c = 1.80, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 5.70 – 5.60 (m, 1H), 5.59 – 5.43 (m, 3H), 4.27 – 4.21 (m, 
1H), 4.17 – 4.08 (m, 1H), 3.65 – 3.54 (m, 2H), 2.99 – 2.92 (m, 1H), 2.84 – 2.74 (m, 1H), 2.32 
– 2.16 (m, 2H), 2.05 (br s, 2H), 1.64 – 1.40 (m, 2H), 0.90 (t, 3H, J = 7.4 Hz), 0.90 (s, 9H), 
0.07 (s, 3H), 0.07 ppm (s, 3H); 
13
C NMR (100 MHz, CDCl3):  = 130.7, 130.2, 128.8, 126.6, 
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76.1, 73.8, 58.4, 30.3, 26.1, 26.0 (3C), 24.3, 18.2, 9.9, −4.2, −4.3 ppm; IR (film): ~  = 3361, 
2929, 2857, 1463, 1253, 1082, 1004, 834, 773, 755, 666 cm
−1
; MS (EI): m/z (%) 239 (12), 
187 (21), 173 (80), 145 (60), 133 (43), 115 (17), 93 (50), 75 (100), 67 (13), 57 (20), 41 (13); 
HRMS (ESI+): m/z: calcd. for C17H34NaO3Si [M+Na
+
]: 337.2169, found: 337.2166. 
Compound syn-13. A solution of PPh3 (84.3 mg, 0.322 mmol) in CH2Cl2 (1.5 mL) was added 
at 0 °C to a solution of compound S4 (77.8 mg, 0.247 mmol) and CBr4 
(107 mg, 0.322 mmol) in CH2Cl2 (3.5 mL). After stirring for 0.5 h at 0 
°C, the reaction was quenched with saturated aqueous NH4Cl and the 
mixture was extracted with tert-butyl methyl ether. The combined extracts were washed with 
water and brine, dried over Na2SO4, and concentrated, and the crude material was purified by 
flash chromatography (SiO2, hexane/EtOAc = 20:1) to give the title compound as a colorless 
oil (85.3 mg, 91%). 
25
D][ = −3.4 (c = 1.05, CHCl3); 
1
H NMR (400 MHz, CDCl3):  = 5.76 
(dtt, 1H, J = 10.4, 8.4, 1.7 Hz), 5.61 – 5.47 (m, 3H), 4.01 (dd, 2H, J = 8.3, 1.0 Hz), 3.66 – 3.57 
(m, 2H), 2.92 (t, 2H, J = 6.6 Hz), 2.31 – 2.14 (m, 2H), 2.06 (br d, 1H, J = 3.5 Hz), 1.64 – 1.40 
(m, 2H), 0.92 (t, 3H, J = 7.5 Hz), 0.91 (s, 9H), 0.09 (s, 3H), 0.08 ppm (s, 3H); 
13
C NMR (100 
MHz, CDCl3):  = 133.7, 128.9, 127.4, 125.8, 76.3, 73.9, 30.1, 27.0, 26.0 (3C), 25.6, 24.1, 
18.3, 10.1, −4.2, −4.3 ppm; IR (film): ~  = 3567, 2930, 2857, 1463, 1253, 1077, 1004, 834, 
774, 754, 668 cm
−1




Compound syn-14. A suspension of CuI (38 mg, 0.20 mmol) in THF (10 mL) was added to a 
solution of 1-propynylmagnesium bromide (0.5 M in THF, 2.38 mL, 
1.19 mmol) at −15 C. After stirring for 0.5 h at −15 C, a solution 
of bromide 13 (150 mg, 0.397 mmol) in THF (4 mL) was slowly 
introduced and stirring was continued for 5 h at −10 C. The reaction was quenched with 
saturated aqueous NH4Cl and the mixture was warmed to ambient temperature before it was 
extracted with tert-butyl methyl ether (3 x). The combined extracts were washed with water 
and brine, dried over Na2SO4, and concentrated. The crude product was purified by flash 
chromatography (SiO2, hexane/EtOAc = 30:1) to give the title compound as a colorless oil 
(108 mg, 81%). For characterization purposes, an aliquot was purified by preparative HPLC 
(UFLC SHIMADZU; Kromasil 100-5C18, 150 x 30 mm; 35 °C, 74 bar, 35 mL/min, 
MeOH/H2O = 85/15). [𝛼]D
20 = +2.5 (c = 0.50, CHCl3), 
1
H NMR (600 MHz, C6D6):  = 5.56 
(dtt, 1H, J = 10.4, 7.0, 1.7 Hz), 5.50 (dtt, 1H, J = 10.7, 7.0, 1.4 Hz), 5.49 (dtt, 1H, J = 10.7, 
6.9, 1.3 Hz), 5.41 (dtt, 1H, J = 10.5, 7.3, 1.7 Hz), 3.58 (dt, 1H, J = 8.5, 4.3 Hz), 3.54 (dt, 1H, 
J = 7.3, 4.2 Hz), 2.91 (ddqt, 2H, J = 7.0, 2.6, 1.9, 0.8 Hz), 2.79 (bt, 2H, J = 6.7 Hz), 2.34 –
 2.23 (m, 2H), 1.77 (br s, 1H), 1.64 (dq, 1H, J = 13.9, 7.4 Hz), 1.55 (t, 3H, J = 2.6 Hz), 1.40 
(ddq, 1H, J = 14.0, 7.4, 4.3 Hz), 0.96 (s, 9H), 0.91 (t, 3H, J 7.5 Hz), 0.07 (s, 3H), 0.06 ppm (s, 
3H); 
13
C NMR (150 MHz, C6D6):  = 130.2, 129.2, 127.0, 126.1, 77.6, 76.8, 75.7, 73.9, 30.6, 
26.1 (3C), 26.0, 25.1, 18.4, 17.7, 10.1, 3.4, −4.2, −4.3 ppm; IR (film): ?̃? = 2956, 2928, 2857, 
S8 
 
1463, 1388, 1361, 1253, 1080, 1005, 939, 909, 834, 792, 774, 730, 671 cm
-1
; MS (pos. ESI) 
m/z (%): 359 (M+Na
+




Compound syn-15. PPh3 (1.96 g, 7.49 mmol) was added at 0 °C to a solution of alcohol 14 
(630 mg, 1.87 mmol) in toluene (62 mL) and the resulting 
mixture was stirred for 10 min before CBr4 (2.48 g, 7.49 mmol) 
was introduced. After stirring for another 10 min, the flask was 
placed into a pre-heated oil bath (65 °C) and stirring continued for 1 h. After cooling to 
ambient temperature, the pale yellow suspension was filtered through a pad of Celite, which 
was carefully rinsed with pentane/EtOAc (20:1). The combined filtrates were concentrated 
and the residue purified by flash chromatography (SiO2, pentane/EtOAc = 200:1) to yield the 
title bromide as a pale yellow oil (445 mg, 60%).
6
 The material is very unstable and can only 
be stored under Ar at −20°C for a few days. For characterization purposes, an aliquot was 
purified by preparative HPLC (UFLC SHIMADZU; Kromasil 100-5C18, 150 x 30 mm; 
25 °C, 61 bar, 35 mL/min, 210 nm, MeOH/H2O = 95/5). [𝛼]D
20 = −16.2 (c = 1.01, CHCl3); 
1
H NMR (600 MHz, C6D6):  = 5.56 (ddt, 1H, J = 10.4, 7.0, 1.7 Hz), 5.53 (dddt, 1H, J = 10.7, 
7.6, 6.2, 1.4 Hz), 5.47 (ddt, 1H, J = 10.7, 7.0, 1.4 Hz), 5.39 (ddt, 1H, J = 10.5, 7.2, 1.7 Hz), 
3.93 (dt, 1H, J = 10.1, 3.5 Hz), 3.63 (ddd, 1H, J = 7.7, 4.6, 3.3 Hz), 2.90 (ddqt, 2H, J = 7.0, 
2.6, 1.9, 0.7 Hz), 2.78 (dq, 1H, J = 16.0, 7.1 Hz), 2.75 (dq, 1H, J = 16.0, 7.1 Hz); 2.69 (dddd, 
1H, J = 15.5, 6.4, 3.6, 1.6 Hz), 2.61 (dddd, 1H, J = 15.2, 9.9, 7.5, 1.2 Hz), 1.89 (ddq, 1H, 
J = 13.6, 7.5, 4.6 Hz), 1.54 (t, 3H, J = 2.6 Hz), 1.44 (dq, 1H, J = 13.7, 7.5 Hz), 0.95 (s, 9H), 
0.81 (t, 3H, J = 7.4 Hz), 0.00 (s, 3H), −0.01 ppm (s, 3H); 13C NMR (150 MHz, C6D6): 
 = 130.1, 128.9, 127.5, 126.3, 77.5, 76.7, 75.8, 59.4, 31.7, 26.3, 26.1, 26.0 (3C), 18.3, 17.7, 
10.5, 3.4, −4.2, −4.3 ppm; IR (film): ?̃? = 2956, 2929, 2857, 1462, 1382, 1361, 1254, 1094, 
1048, 1005, 834, 794, 774, 726, 671 cm
-1
; MS (pos. ESI) m/z (%): 421 (M+Na
+
, 100); HRMS 
(ESI): m/z: calcd. for C20H35OBrSiNa [M
+
+Na]: 421.1536, found 421.1533.  
For an unambiguous assignment of the NMR data, see Table S-1 
Compound syn-16. In a Teflon vial, a solution of compound 15 (432 mg, 1.08 mmol) in THF 
(18 mL) was cooled to 0 °C before HF∙pyridine (70% HF, 
3.41 mL, 37.8 mmol) was slowly added. The resulting mixture 
was stirred for 5 h at 0 °C before it was diluted with ethyl acetate 
(10 mL) and H2O (5 mL). Next, a sat. aq. solution of NaHCO3 was added until the evolution 
of gas ceased. The mixture was then extracted with EtOAc, the combined organic phases were 
washed with brine, dried over Na2SO4 and concentrated. The residue was purified by flash 
chromatography (SiO2, pentane/EtOAc = 15:1) to yield the title compound as a colorless oil 
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 The material is very unstable and should be immediately used in the next 
step. For characterization purposes, an aliquot was purified by preparative HPLC (UFLC 
SHIMADZU; Kromasil 100-5C18, 150 x 30 mm; 35 °C, 70 bar, 35 mL/min, 210 nm, 
MeOH/H2O = 75/25). [𝛼]D
20 = −18.6 (c = 0.56, CHCl3); 
1
H NMR (600 MHz, C6D6):  = 5.53 
(dtt, 1H, J = 10.5, 7.0, 1.7 Hz), 5.42 (dtt, 1H, J = 10.7, 7.3, 1.6 Hz), 5.34 (dtt, 1H J = 10.4, 
7.3, 1.7 Hz), 5.30 (dtt, 1H, J = 10.7, 7.3, 1.7 Hz), 3.73 (ddd, 1H, J = 7.9, 6.3, 2.9 Hz), 3.10 (m, 
1H), 2.88 (ddqt, 2H, J = 7.0, 2.6, 1.8, 0.8 Hz), 2.70 (m, 2H), 2.60 (dddt, 1H, J = 15.0, 7.3, 6.3, 
1.5 Hz), 2.56 (dddt, 1H, J = 15.0, 7.9, 7.2, 1.5 Hz), 1.55 (t, 3H, J = 2.6 Hz), 1.38 (dq, 1H, 
J = 13.7, 7.4 Hz), 1.35 – 1.33 (m, 1H), 1.30 (ddq, 1H, J = 13.7, 7.4, 4.7 Hz), 0.79 ppm (t, 3H, 
J = 7.4 Hz); 
13
C NMR (150 MHz, C6D6):  = 130.6, 128.8, 126.8, 126.2, 77.6, 75.8, 74.2, 
63.3, 34.0, 29.1, 26.0, 17.7, 10.2, 3.4 ppm; IR (film): ?̃? = 3436, 3020, 2964, 2920, 1710, 
1424, 1375, 1222, 1112, 1059, 969, 792, 681, 535, 482 cm
-1
; MS (EI) m/z (%): 187 (11), 147 
(17), 145 (23), 133 (24), 132 (10), 131 (42), 129 (10), 121 (18), 119 (34), 118 (15), 117 (40), 
115 (11), 107 (14), 106 (12), 105 (86), 93 (29), 92 (24), 91 (100), 85 (40), 81 (16), 79 (55), 78 
(13), 77 (40), 69 (19), 67 (24), 65 (14), 59 (32), 57 (85), 55 (22), 53 (20), 43 (12), 41 (39), 39 
(17), 29 (20); HRMS (ESI): m/z: calcd. for C14H21OBrNa [M
+
+Na]: 307.0667, found 
307.0668.  
Compound 20. A solution of LiHMDS was prepared by dropwise addition of n-BuLi (1.6 M 
in hexanes, 60.8 mL, 97.2 mmol) to a stirred solution of hexamethyldisilazane (20.3 mL, 
97.2 mmol) in THF (50 mL) at –78 C. Once the addition was complete, the mixture was 
stirred at 0 C for 0.5 h prior to use.  
The LiHMDS solution was cooled to –78 C before it was transferred via 
cannula to a solution of 1,7-octadiyne (12.9 mL, 97.2 mmol) in THF (135 mL) 
at –78 C. After stirring for 0.5 h, chlorotrimethylsilane (12.3 mL, 97.2 mmol) 
was added dropwise. The mixture was stirred for 10 min before it was allowed to reach 
ambient temperature. After stirring for 2 h, the reaction was quenched with water (200 mL). 
The mixture was extracted with pentane (3 x) and the combined extracts were successively 
washed with HCl (1 M, 200 mL), water (200 mL), and brine (100 mL) before they were dried 
over MgSO4 and concentrated. Distillation of the crude product (Vigreux column, bp 75 – 
78.5 C, 7 mbar) gave the title compound as a colorless oil (9.10 g, 52%). 1H NMR (400 
MHz, CDCl3):  = 2.28 – 2.18 (m, 4H), 1.94 (t, 1H, J = 2.7 Hz), 1.67 – 1.59 (m, 4H), 
0.14 ppm (s, 9H); 
13
C NMR (100 MHz, CDCl3):  = 107.0, 84.9, 84.3, 68.6, 27.7, 27.6, 19.5, 
18.1, 0.3 ppm (3C); IR (film): ~  = 3305, 2949, 2174, 1249, 837, 758, 697 cm−1; MS (EI): m/z 
(%) 163 (47), 145 (16), 135 (72), 119 (10), 109 (20), 95 (14), 83 (33),73 (93), 69 (12), 59 
(100), 55 (12), 43 (25); HRMS (EI): m/z: calcd. for C11H19Si [M+H
+
]: 179.1256, found: 
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The remainder of the distillation was re-distilled in a Kugelrohr apparatus (100–120 C, 
0.09 mbar) to give the corresponding disilylated product (4.07 g, 17%) as a 
colorless oil. 
1
H NMR (400 MHz, CDCl3):  = 2.28 – 2.18 (m, 4H), 1.65 – 1.56 
(m, 4H), 0.13 ppm (s, 18H); 
13
C NMR (100 MHz, CDCl3):  = 107.1 (2C), 84.8 
(2C), 27.8 (2C), 19.5 (2C), 0.3 ppm (2C); IR (film): ~  = 2957, 2174, 1248, 835, 757, 697 
cm
−1
; MS (EI): m/z (%) 162 (29), 147 (13), 73 (100), 67 (4), 59 (21); HRMS (EI): m/z: calcd. 
for C14H26Si2 [M
+
]: 250.1573, found: 250.1571. The NMR data are in good agreement with 
those previously reported in the literature.
10
 
Compound S5. n-BuLi (1.6 M in hexanes, 39.9 mL, 63.9 mmol) was added dropwise to a 
solution of compound 20 (7.60 g, 42.6 mmol) in THF (200 mL) at –78 C. 
After stirring for 1 h, iodomethane (5.30 mL, 85.2 mmol) was slowly 
introduced, the mixture was allowed to warm to ambient temperature while 
stirring was continued for 2 h. For work up, the reaction was quenched with water at 0 C and 
the mixture was extracted with pentane (3 x). The combined extracts were washed with water 
and brine, dried over Na2SO4, and concentrated. The crude product was purified by 
distillation (bp 119 – 125 C, 20 mbar) to give the title compound as a colorless oil (7.42 g, 
91%). 
1
H NMR (400 MHz, CDCl3):  = 2.22 (t, 2H, J = 6.9 Hz), 2.17 – 2.10 (m, 2H), 1.76 (t, 
3H, J = 2.5 Hz), 1.65 – 1.51 (m, 4H), 0.13 ppm (s, 9H); 13C NMR (100 MHz, CDCl3):  = 
107.3, 84.7, 78.9, 75.8, 28.3, 27.9, 19.6, 18.4, 3.6, 0.3 ppm (3C); IR (film): ~  = 2946, 2174, 
1248, 837, 758, 697 cm
−1
; MS (EI): m/z (%) 177 (18), 149 (21), 135 (11), 118 (17), 97 (16), 
83 (13), 73 (100), 67 (6), 59 (40), 43 (10); HRMS (CI): m/z: calcd. for C12H21Si [M+H
+
]: 
193.1413, found: 193.1411. The 
1
H NMR data are in good agreement with those previously 
reported in the literature.
8
 
Compound 21. MeLi (1.6 M in ether, 23.7 mL, 37.9 mmol) was added dropwise to a solution 
of S5 (3.65 g, 19.0 mmol) in THF (73 mL) at –78 C. After stirring for 10 
min, the mixture was stirred at 0 C for an additional 6 h. After cooling to –78 
C, methyl chloroformate (3.70 mL, 47.9 mmol) was slowly added, the 
mixture was stirred for 0.5 h at this temperature and for 10 min at 0 °C. The reaction was then 
quenched with saturated aqueous NaHCO3 (50 mL) and the mixture was extracted with tert-
butyl methyl ether (3 x). The combined extracts were washed with water and brine, dried over 
Na2SO4, and concentrated, and the crude product purified by flash chromatography (SiO2, 
hexanes/EtOAc = 20:1) to give the title compound as a colorless oil (2.90 g, 86%). 
1
H NMR 
(400 MHz, CDCl3):  = 3.73 (s, 3H), 2.34 (t, 2H, J = 7.0 Hz), 2.18 – 2.10 (m, 2H), 1.75 (t, 
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3H, J = 2.4 Hz), 1.72 – 1.62 (m, 2H), 1.62 – 1.52 ppm (m, 2H); 13C NMR (100 MHz, CDCl3): 
 = 154.3, 89.5, 78.4, 76.2, 73.1, 52.6, 28.0, 26.7, 18.3, 18.3, 3.5 ppm; IR (film): ~  = 2951, 
2235, 1712, 1434, 1248, 1076, 751 cm
−1
; MS (EI): m/z (%) 177 (15), 163 (14), 149 (15), 135 
(22), 131 (6), 119 (53), 117 (54), 105 (23), 91 (100), 79 (59), 66 (31), 59 (13), 53 (57), 41 
(48), 27 (33); HRMS (CI): m/z: calcd. for C11H15O2 [M+H
+
]: 179.1072, found: 179.1074. The 
1
H NMR and IR data are in good agreement to those previously reported in the literature.
11
 
Compound S6. n-BuLi (1.6 M in hexanes, 6.57 mL, 10.5 mmol) was added to a solution of 
diisopropylamine (1.48 mL, 10.5 mmol) in THF (15 mL) at –78 C and the 
resulting mixture was stirred at 0 C for 5 min prior to use.  
The resulting LDA solution was cooled to –78 C before neat t-butyl acetate 
(1.41 mL, 10.5 mmol) was added. After stirring for 0.5 h, a solution of 21 (950 mg, 
5.33 mmol) in THF (15 mL) was added dropwise and the mixture was stirred for 2 h at –78 
C before it was carefully poured into saturated aqueous NH4Cl (5 mL). The mixture was 
extracted with tert-butyl methyl ether (3 x) and the combined extracts were washed with 
water and brine before they were dried over Na2SO4 and concentrated, keeping the 
temperature below 30°C. The residue was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 20:1) to give the title compound as yellow oil (166 mg, 87%). The 
compound must be kept in a freezer under Ar to avoid decomposition. 
1
H NMR (400 MHz, 
CDCl3, mixture of keto/enol tautomers):  = 12.01 (s, 0.18H), 5.20 (s, 0.18), 3.45 (s, 1.38), 
2.43 – 2.35 (m, 2H), 2.20 – 2.11 (m, 2H), 1.77 (br s, 3H), 1.74 – 1.64 (m, 2H), 1.64 – 1.53 (m, 
2H), 1.47 ppm (s, 9H); 
13
C NMR (100 MHz, CDCl3):  = 179.6, 165.5, 98.0, 95.9, 82.3, 78.4, 
76.3, 52.9, 28.4, 28.1 (3C), 26.8, 18.8, 18.3, 3.6 ppm; IR (film): ~  = 2933, 2213, 1732, 1677, 
1610, 1393, 1368, 1323, 1254, 1135, 956, 837, 732 cm
−1
; MS (EI): m/z (%) 205 (13), 189 
(14), 177 (37), 161 (15), 146 (32), 119 (21), 91 (25), 57 (100), 53 (11), 41 (28), 29 (11); 
HRMS (ESI+): m/z: calcd. for C16H22NaO3 [M+Na
+
]: 285.1461, found: 285.1461. 
Compound 22. A solution of S6 (1.00 g, 3.81 mmol) and trifluoroacetic acid (5.0 mL) in 
CH2Cl2 (5 mL) was stirred for 0.5 h. All volatile materials were distilled off 
and the remaining brown oil was purified by flash chromatography (SiO2, 
hexanes/EtOAc = 5:1  EtOAc) to give the title compound as a pale brown 
solid (777 mg, 99%). This product has to be used without delay as it gradually decomposes 
even if stored at −20 °C. 1H NMR (400 MHz, CDCl3, mixture of keto/enol tautomers):  = 
11.56 (br s, 0.33H), 5.32 (s, 0.33H), 3.63 (s, 1.28H), 2.42 (t, 2H, J = 6.9 Hz), 2.20 – 2.11 (m, 
2H), 1.76 (t, 3H, J = 2.5 Hz), 1.74 – 1.63 (m, 2H), 1.63 – 1.52 ppm (m, 2H); IR (film): ~  = 
2936, 2214, 1650, 1574, 1455, 1252, 1183, 1040, 965, 901, 804, 721, 689 cm
−1
; MS (EI): m/z 
(%) 161 (18), 147 (50), 119 (51), 105 (17), 91 (66), 77 (26), 65 (16), 53 (35), 43 (100), 27 
(23); HRMS (ESI−): m/z: calcd. for C12H13O3 [(M−H)
−
]: 205.0870, found: 205.0872. 
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Compound syn-23. A solution of acid 22 (298 mg, 1.45 mmol) in CH2Cl2 (16 mL) was added 
at 0 C to a solution of alcohol 16 (165 mg, 0.58 mmol) in CH2Cl2 
(16 mL). DCC (298 mg, 1.45 mmol) was then introduced, 
followed by DMAP (21 mg, 30 mol%). The mixture was stirred at 
0°C for 0.5 h before it was diluted with tert-butyl methyl ether. 
The resulting suspension was filtered through a pad of Celite and 
the filtrate was concentrated. The residue was triturated with a 
mixture of hexanes/tert-butyl methyl ether (2:1) and the resulting suspension was filtered 
through a pad of Celite. After evaporation of the filtrate, the residue was purified by flash 
chromatography (SiO2, hexanes/EtOAc = 10:1  5:1) to give the highly unstable title 
compound as a yellow oil, which was directly used in the next step without further 
purification (208 mg, 76%, mixture of keto/enol tautomers). [𝛼]D
20 = −13.2 (c = 0.55, CHCl3). 
MS (pos. ESI) m/z (%): 495 (M+Na, 100); HRMS (ESI): m/z: calcd. for C26H33O3BrNa 
[M
+
+Na]: 495.1507, found 495.1505.  
Compound syn-25. [(SPhos)Au]NTf2 (6.2 mg, 7.0 mol, 3 mol%)
12
 was added to a solution 
of the -keto ester 23 (110 mg, 0.23 mmol) in MeCN/AcOH (5:1, 
7.7 mL). The mixture was stirred for 38 h at ambient temperature 
before it was concentrated. The residue was purified by flash 
chromatography (SiO2, hexanes/ EtOAc = 1:1  EtOAc) to give 
the title compound as a colorless oil (105 mg, 97%). For 
characterization purposes, an aliquot was purified by preparative 
HPLC (UFLC SHIMADZU; Kromasil 100-5C18, 150 x 30 mm; 
25 °C, 75 bar, 35 mL/min, 244 nm, MeOH/H2O = 85/15). [𝛼]D
20 = −41.9 (c = 0.44, CHCl3); 
1
H NMR (600 MHz, C6D6):  = 5.95 (dt, 1H, J = 1.8, 0.7 Hz), 5.63 (d, 1H, J = 1.9 Hz), 5.52 
(dtt, 1H, J = 10.5, 7.0, 1.7 Hz), 5.41 (dtt, 1H, J = 10.7, 7.4, 1.6 Hz), 5.28 (dtt, 1H, J = 10.5, 
7.3, 1.8 Hz), 5.22 (dtt, 1H, J = 10.7, 7.1, 1.7 Hz), 4.01 (ddd, 1H, J = 7.2, 5.8, 3.5 Hz), 3.75 
(ddd, 1H, J = 8.2, 5.9, 3.5 Hz), 2.84 (ddqt, 2H, J = 7.0, 1.8, 2.6, 0.8 Hz), 2.64 (dt, 1H, 
J = 15.8, 7.4 Hz), 2.60 (dt, 1H, J = 15.8, 7.3 Hz), 2.52 – 2.47 (m, 2H), 1.91 (tq, 2H, J = 7.0, 
2.6 Hz), 1.85 (dd, 2H, J = 7.4, 0.7 Hz), 1.61 (ddq, 1H, J = 14.2, 5.8, 7.5 Hz), 1.56 (t, 3H, 
J = 2.5 Hz), 1.55 (t, 3H, J = 2.6 Hz), 1.52 (dq, 1H, J = 14.2, 7.3 Hz), 1.38 – 1.32 (m, 2H), 
1.21 – 1.16 (m, 2H), 0.81 ppm (t, 3H, J = 7.5 Hz); 13C NMR (150 MHz, C6D6):  = 180.9, 
166.8, 164.8, 131.2, 128.4, 126.4, 125.8, 112.8, 92.0, 82.5, 78.7, 77.4, 76.2, 75.9, 54.3, 32.8, 
32.3, 28.4, 25.9, 25.8, 24.7, 18.7, 17.6, 9.4, 3.4, 3.4 ppm; IR (film): ?̃? = 2919, 1659, 1577, 
1404, 1240, 1157, 928, 858, 679 cm
-1
; MS (EI) m/z (%): 393 (23), 208 (13), 207 (100), 187 
(32), 165 (25), 159 (16), 147 (16), 146 (12), 145 (47), 143 (12), 135 (11), 132 (16), 131 (60), 
129 (13), 123 (11), 119 (24), 118 (11), 117 (40), 111 (24), 109 (11), 107 (18), 106 (10), 105 
(57), 95 (31), 93 (36), 92 (13), 91 (64), 81 (45), 80 (12), 79 (51), 77 (20), 69 (20), 55 (29), 53 
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(11), 43 (13), 41 (24); HRMS (ESI): m/z: calcd. for C26H33O3BrNa [M
+
+Na]: 495.1507, found 
495.1505.  
Compound syn-27. Activated MS 5 Å (powder, 440 mg) was added to a solution of diyne 25 
(30.0 mg, 63.0 mol) in toluene (60 mL) and the resulting suspension was 
stirred for 0.5 h before a solution of the molybdenum alkylidyne complex 
26 (3.3 mg, 3.2 mol, 5 mol%)13 in toluene (0.05 mL) was added. After 
stirring for 2 h at rt, the suspension was filtered through a pad of Celite 
which was thoroughly rinsed with acetone. The combined filtrates were 
concentrated and the residue was purified by flash chromatography (SiO2, EtOAc  
EtOAc/acetone = 1:1) to give the title compound as a colorless oil (21.7 mg, 82%). An aliquot 
was purified by preparative HPLC (UFLC SHIMADZU; Kromasil 100-5C18, 150 x 20 mm; 
35 °C, 55 bar, 25 mL/min, 240 nm, MeCN/H2O = 60/40). [𝛼]D
20 = −42.1 (c = 1.05, CHCl3), 
1
H NMR (600 MHz, C6D6):  = 5.87 (d, 1H, J = 1.8 Hz), 5.51 (d, 1H, J = 1.8 Hz), 5.48 – 5.45 
(m, 1H), 5.46 – 5.42 (m, 1H), 5.33 (dtt, 1H, J = 10.3, 6.9, 1.3 Hz), 5.20 (dtt, 1H, J = 10.7, 7.3, 
1.7 Hz), 3.75 (td, 1H, J = 6.8, 2.6 Hz), 3.63 (ddd, 1H, J = 9.5, 4.9, 2.6 Hz), 2.83 (dddt, 1H, 
J = 17.4, 8.0, 1.4, 2.1 Hz), 2.79 (dt, 1H, J = 16.3, 7.4 Hz), 2.73 (dt, 1H, J = 16.3, 6.9 Hz), 2.68 
– 2.64 (m, 1H), 2.54 (dddt, 1H, J = 15.1, 9.5, 7.2, 1.6 Hz), 2.44 (dddt, 1H, J = 15.1, 7.3, 4.9, 
1.6 Hz), 1.93 – 1.87 (m, 3H), 1.67 (dt, 1H, J = 14.2, 7.8 Hz), 1.65 – 1.55 (m, 2H), 1.44 – 1.37 
(m, 2H), 1.09 – 0.99 (m, 2H), 0.55 ppm (t, 3H, J = 7.5 Hz); 13C NMR (150 MHz, C6D6): 
 = 180.3, 166.7, 164.5, 131.0, 129.9, 126.0, 125.2, 113.1, 91.5, 82.1, 79.3, 79.2, 54.4, 33.1, 
32.6, 27.6, 26.2, 26.0, 24.9, 18.6, 17.3, 9.5 ppm; MS (pos. ESI) m/z (%): 441 (M+Na
+
, 100); 
HRMS (ESI): m/z: calcd. for C22H27O3BrNa [M
+
+Na]: 441.1037, found 441.1036.  
For an unambiguous assignment of the NMR data, see Table S-2 
 Compound syn-1. N-Bromosuccinimide (4.2 mg, 2.4 µmol) was added in solid form to a 
solution of compound 27 (11 mg, 2.6 µmol) in THF (1.1 mL) at 0 °C. The 
resulting pale yellow solution was immediately warmed to ambient 
temperature and the reaction closely monitored by thin layer 
chromatography (pentane/EtOAc = 1:1). After complete consumption of 
the starting material, the mixture was diluted with pentane and filtered 
through a pad of Celite, which was carefully rinsned with pentane/EtOAc 
(1:1). The combined filtrates were concentrated and the residue was purified by flash 
chromatography (SiO2, pentane/EtOAc = 1:1  EtOAc 100%) to give the title compound as a 
colorless solid (5.3 mg, 40%). Crystals suitable for X-ray diffraction were grown form MeCN. 
An analytically pure sample was obtained by preparative HPLC (UFLC SHIMADZU; 
Kromasil 100-5C18, 150 x 20 mm; 35 °C, 50 bar, 20 mL/min, 264 nm, MeCN/H2O = 60/40). 
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M.p. = 105 – 108 °C; [𝛼]D
20 = −13.8 (c = 0.25, CHCl3). 
1
H NMR (600 MHz, CDCl3):  = 6.13 
(s, 1H), 5.67 (dddt, 1H, J = 10.7, 7.6, 7.1, 1.4 Hz), 5.55 (dtt, 1H, J = 10.7, 7.1, 1.6 Hz), 5.51 – 
5.45 (m, 2H), 4.80 (ddd, 1H, J = 7.4, 5.4, 4.6 Hz), 4.14 (ddd, 1H, J = 8.3, 5.5, 4.6 Hz), 2.91 – 
2.88 (m, 2H), 2.90 – 2.78 (m, 2H), 2.73 (dddd, 1H, J = 15.1, 7.2, 5.4, 1.5 Hz), 2.72 (dddd, 1H, 
J = 15.2, 8.3, 7.0, 1.5 Hz), 2.56 (ddd, 1H, J = 14.7, 8.5, 6.4 Hz), 2.53 (ddd, 1H, J = 14.6, 8.4, 
6.9 Hz), 2.26 – 2.24 (m, 2H), 1.96 (ddq, 1H, J = 14.3, 5.4, 7.5 Hz), 1.92 (dq, 1H, J = 14.3, 
7.3 Hz), 1.83 (dtt, 1H, J = 13.9, 8.5, 6.8 Hz), 1.79 (dtt, 1H, J = 13.7, 8.5, 6.8 Hz), 1.57 – 1.52 
(m, 2H), 1.03 ppm (t, 3H, J = 7.4 Hz); 
13
C NMR (150 MHz, CDCl3):  = 175.8, 163.1, 162.0, 
130.8, 129.4, 125.9, 125.0, 111.8, 92.2, 84.6, 79.2, 79.0, 55.1, 33.6, 32.7, 27.8, 26.5, 26.4, 
26.1, 18.6, 17.4, 9.7 ppm; IR (film): ?̃? = 2926, 1659, 1573, 1459, 1379, 1324, 1262, 1157, 
1091, 1013, 975, 918 cm
-1
; MS (EI) m/z (%): 506 (32), 505 (82), 420 (13), 419 (25), 417 (26), 
338 (12), 337 (17), 235 (19), 219 (29), 217 (28), 206 (21), 199 (20), 197 (20), 195 (21), 185 
(38), 181 (23), 173 (25), 171 (59), 169 (34), 159 (25), 157 (44), 145 (44), 143 (58), 141 (27), 
133 (33), 131 (62), 129 (87), 119 (32), 117 (81), 115 (29), 105 (57), 97 (22), 95 (33), 93 (38), 
91 (100), 81 (42), 80 (14), 79 (58), 69 (25), 67 (50), 55 (40); HRMS (ESI): m/z: calcd. for 
C22H26O3Br2Na [M
+
+Na]: 519.0138, found 519.0141.  
For an unambiguous assignment of the NMR data and a comparison with those of the natural 
product, see Tables S-3 and S-4 
Synthesis of the anti-Isomer 
Compound S7. A solution of Dess-Martin periodinane (265 mg, 0.624 mmol) in CH2Cl2 
(0.5 mL) was added to a solution of alcohol 16 (140 mg, 
0.416 mmol) in CH2Cl2 (8.7 mL) at 0 °C. The mixture was stirred 
for 10 min at 0°C and for 2 h at ambient temperature before the 
reaction was quenched with saturated aqueous NaHCO3 and saturated aqueous Na2SO3 (1:1, 
2 mL). The resulting slurry was vigorously stirred for 5 min before the aqueous phase was 
extracted (3x) with EtOAc. The combined organic phases were dried over Na2SO4 and the 
solvent was removed under reduced pressure. The resulting ketone (138 mg, 99%) was 
immediately used in the next step without further purification.  
Compound S8. A solution of ketone S7 (138 mg, 0.413 mmol) in toluene (8.0 mL) was 
added to a solution of (S)-()-1-methyl,3,3-diphenyl-tetrahydro-
pyrrolo(1,2-c)(1,3,2)oxazaborole ((S)-CBS reagent, 343 mg, 
1.24 mmol)
14
 in toluene (1.8 mL). After cooling to −78 °C a 
solution of catecholborane (149 mg, 1.24 mmol)
15
 in toluene (3 mL) was added via syringe 
pump over the course of 5 h. Once the addition was complete, the mixture was stirred for 12 h 
                                                          
14
  E. J. Corey, C. Helal, Angew. Chem. 1998, 110, 2092; Angew. Chem. Int. Ed. 1998, 37, 1986. 
15
  For the modified procedure using catecholborane as hydride source to allow for CBS-reductions in 
the presence of alkynes, see: a) A. Fürstner, M. Bindl, L. Jean, Angew. Chem. Int. Ed. 2007, 46, 
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at −78 °C. The reaction was then quenched with MeOH (2 mL) at this temperature and the 
resulting slurry stirred at ambient temperature for 1 h. The mixture was washed twice with 
NaOH (0.2 M, 3.0 mL) and the aqueous layers were extracted with EtOAc (3 x). The 
combined organic phases were washed with brine, dried over Na2SO4 and concentrated, and 
the crude product was purified by flash chromatography (SiO2, pentane/EtOAc = 50:1  
pentane/EtOAc = 30:1) to yield the title alcohol as a colorless oil (112 mg, 81%). An 
analytically pure sample was obtained by preparative HPLC (UFLC SHIMADZU; Kromasil 
100-5C18, 150 x 30 mm; 35 °C, 70 bar, 35 mL/min, 210 nm, MeOH/H2O = 85/15). 
[𝛼]D
20 = −2.4 (c = 0.40, CHCl3). 
1
H NMR (600 MHz, C6D6):  = 5.61 (dtt, 1H, J = 10.8, 7.3, 
1.6 Hz), 5.57 (dtt, 1H, J = 10.5, 7.0, 1.8 Hz), 5.50 (dtt, 1H, J = 10.8, 7.3, 1.6 Hz), 5.43 (dtt, 
1H, J = 10.5, 7.2, 1.7 Hz), 3.54 (dt, 1H, J = 8.5, 4.1 Hz), 3.45 (dt, 1H, J = 5.8, 4.1 Hz), 2.92 
(ddqt, 2H, J = 6.2, 2.6, 1.8, 0.8 Hz), 2.89 – 2.77 (m, 2H), 2.31 – 2.27 (m, 1H), 2.25 – 2.20 (m, 
1H), 1.97 (br s, 1H), 1.67 (dq, 1H, J = 7.7, 6.0 Hz), 1.55 (t, 3H, J = 2.6 Hz), 1.44 – 1.37 (m, 
1H), 0.94 (s, 9H), 0.86 (t, 3H, J = 7.5 Hz), 0.04 (s, 3H), 0.03 ppm (s, 3H); 
13
C NMR 
(150 MHz, C6D6):  = 129.6, 129.2, 127.2, 126.1, 77.6, 76.5, 75.7, 72.8, 32.0, 26.6, 26.1, 26.1 
(3C), 18.4, 17.7, 9.8, 3.4, −4.1, −4.4 ppm; IR (film): ?̃? = 2955, 2929, 2884, 2857, 1463, 1389, 
1361, 1254, 1056, 1005, 939, 834, 774, 676 cm
-1
; MS (EI) m/z (%): 336 (1), 279 (8), 203 (25), 
187 (44), 174 (14), 173 (91), 145 (32), 134 (11), 133 (100), 131 (23), 119 (13), 117 (28), 115 
(36), 93 (12), 91 (13), 75 (70), 73 (60); HRMS (ESI): m/z: calcd. for C20H36OSiNa [M
+
+Na]: 
359.2377, found 359.2377.  
Compound S9. PPh3 (341 mg, 1.30 mmol) was added to a solution of alcohol S8 (97 mg, 
0.288 mmol) in toluene (11 mL) at 0 °C and the resulting mixture 
was stirred for 10 min before CBr4 (431 mg, 1.30 mmol) was 
introduced. After stirring for another 10 min, the flask was placed 
into a pre-heated oil bath (65 °C) and the mixture stirred at this temperature for 1 h. For work 
up, the mixture was cooled to ambient temperature before it was filtered through a pad of 
Celite which was carefully rinsed with pentane/EtOAc (20:1). The combined filtrates were 
concentrated and the residue was purified by flash chromatography (SiO2, 
pentane/EtOAc = 200:1) to yield the title bromide as a pale yellow oil (64 mg, 55%).
16
 The 
material is very unstable and can be stored under Ar at −20°C only for a few days. An 
analytically pure sample was obtained by preparative HPLC (UFLC SHIMADZU; Kromasil 
100-5C18, 150 x 20 mm; 35 °C, 53 bar, 20 mL/min, 210 nm, MeOH/H2O = 95/5). 
[𝛼]D
20 = +9.0 (c = 0.30, CHCl3). 
1
H NMR (600 MHz, C6D6):  = 5.56 (dtt, 1H, J = 10.5, 7.1, 
1.7 Hz), 5.51 (dtt, 1H, J = 10.7, 6.7, 1.6 Hz), 5.46 (dtt, 1H, J = 10.7, 7.0, 1.3 Hz), 5.39 (dtt, 
1H, J = 10.5, 7.3, 1.7 Hz), 3.95 (ddd, 1H, J = 9.5, 4.7, 4.3 Hz), 3.72 (dt, 1H, J = 5.2, 4.7 Hz), 
                                                                                                                                                                                     
9275; b) M. Bindl, L. Jean, J. Herrmann, R. Müller, A. Fürstner, Chem. Eur. J. 2009, 15, 12310-
12319. 
16
  The material contains ca.11% of elimination byproduct and ca. 20% of trans-isomerized byproduct.  
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2.90 (ddqt, 2H, J = 7.0, 1.8, 2.6, 0.8 Hz), 2.76 – 2.73 (m, 2H), 2.68 (dddd, 1H, J = 15.3, 6.8, 
4.2, 1.3 Hz), 2.56 (dddd, 1H, J = 15.5, 9.5, 6.8, 1.2 Hz), 1.80 (ddq, 1H, J = 14.0, 6.2, 7.4 Hz), 
1.54 (t, 3H, J = 2.6 Hz), 1.43 (ddq, 1H, J = 14.0, 4.6, 7.4 Hz), 0.99 (s, 9H), 0.82 (t, 3H, 
J = 7.5 Hz), 0.10 (s, 3H), 0.03 ppm (s, 3H); 
13
C NMR (150 MHz, C6D6):  = 130.0, 128.9, 
127.4, 126.3, 77.5, 76.7, 75.8, 59.5, 32.3, 27.5, 26.1 (3C), 26.0, 18.4, 17.7, 9.1, 3.4, −4.2, 
−4.3 ppm; IR (film): ?̃? = 2959, 2928, 2856, 1462, 1258, 1091, 1014, 836, 794, 777, 674 cm-1; 
MS (EI) m/z (%): 319 (11), 197 (70), 195 (71), 187 (24), 173 (39), 159 (38), 145 (41), 139 
(38), 137 (37), 135 (2), 133 (56), 131 (59), 119 (21), 117 (38), 115 (43), 107 (12), 93 (30), 91 
(71), 79 (36), 75 (68), 73 (100), 67 (26), 55 (28); HRMS (ESI): m/z: calcd. for 
C20H35OBrSiNa [M
+
+Na]: 421.1535, found 421.1533. 
For an unambiguous assignment of the NMR data, see Table S-5 
Compound S10. HF∙pyridine (70% HF, 0.20 mL, 2.22 mmol) was added dropwise to a 
solution of bromide S9 (47 mg, 0.12 mmol) in THF (1.0 mL) at 
0 °C. The mixture was then stirred at ambient temperature for 4 h 
before it was cooled to 0 °C and diluted with EtOAc and H2O. 
Saturated aqueous NaHCO3 was added until the evolution of gas ceased. The mixture was 
extracted with EtOAc, the combined organic phases were washed with brine, dried over 
Na2SO4 and concentrated, and the crude material was purified by flash chromatography (SiO2, 
pentane/EtOAc = 15:1) to yield the title alcohol as a colorless oil (18.5 mg, 55%). 
[𝛼]D
20 = +19.2 (c = 0.10, CHCl3). 
1
H NMR (600 MHz, C6D6):  = 5.55 (dtt, 1H, J = 10.5, 7.0, 
1.7 Hz), 5.45 – 5.39 (m, 2H), 5.35 (dtt, 1H, J = 10.5, 7.3, 1.8 Hz), 3.79 (dt, 1H, J = 9.4, 
4.3 Hz), 3.35 (dt, 1H, J = 8.7, 4.3 Hz), 2.88 – 2.85 (m, 2H), 2.69 – 2.66 (m, 2H), 2.56 – 2.51 
(m, 1H), 2.46 – 2.42 (m, 1H), 1.54 (t, 3H, J = 2.7 Hz), 1.41 – 1.40 (m, 1H), 1.38 – 1.35 (m, 
2H), 0.82 ppm (t, 3H, J = 7.5 Hz); 
13
C NMR (150 MHz, C6D6):  = 130.1, 128.9, 127.1, 
126.2, 77.5, 75.9, 75.8, 62.5, 31.6, 27.0, 26.0, 17.7, 10.4, 3.4 ppm; IR (film): ?̃? = 2963, 2923, 
2359, 1738, 1670, 1456, 1259, 1013, 705, 681, 561, 432 cm
-1
; MS (EI) m/z (%): 187 (11), 147 
(17), 145 (23), 133 (24), 132 (10), 131 (42), 121 (18), 119 (34), 118 (15), 117 (40), 115 (11), 
107 (14), 106 (12), 105 (86), 93 (29), 91 (100), 85 (40), 81 (16), 79 (55), 77 (40), 59 (32), 57 
(85), 41 (39); HRMS (ESI): m/z: calcd. for C14H21OBrNa [M
+
+Na]: 307.0669, found 
307.0668. 
Compound anti-23. A solution of carboxylic acid 22 (16 mg, 77 mol) in CH2Cl2 (0.6 mL) 
was added at 0 C to a solution of alcohol S10 (10 mg, 35 mol) in 
CH2Cl2 (1 mL). DCC (16 mg, 77 mol) was then introduced at this 
temperature, followed after 5 min by DMAP (1.3 mg, 11 mol, 
30 mol%). The mixture was stirred for 15 min at 0°C before it was 
diluted with tert-butyl methyl ether (3 mL). The resulting 
suspension was filtered through a pad of Celite and the filtrate was 
concentrated. The residue was triturated with a mixture of hexanes/tert-butyl methyl ether 
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(2:1) and the resulting suspension filtered through a pad of Celite. Evaporation of the filtrate 
followed by purification of the residue by flash chromatography (SiO2, hexanes/EtOAc = 15:1 
 13:1) gave the highly unstable title compound as yellow oil which was directly used in the 
next step without further purification (13 mg, 78%), mixture of keto/enol tautomers). 
Compound anti-25. AuSPhosNTf2 (0.4 mg, 0.7 mol, 3 mol%)
12
 was added to a solution of 
anti-23 (10 mg, 21 mol) in MeCN/AcOH (5:1, 1.5 mL). The 
mixture was stirred for 38 h before all volatile materials were 
evaporated. Purification of the crude product by flash 
chromatography (SiO2, hexanes/ EtOAc = 1:1  EtOAc) gave the 
title compound as a colorless oil (8.4 mg, 84%). An analytically pure 
sample was obtained by preparative HPLC (UFLC SHIMADZU; 
Kromasil 100-5C18, 150 x 20 mm; 35 °C, 55 bar, 20 mL/min, 
228 nm, MeCN/H2O = 60/40). [𝛼]D
20 = +13.6 (c = 0.09, CHCl3). 
1
H NMR (600 MHz, C6D6): 
 = 5.92 (d, 1H, J = 1.8 Hz), 5.59 (d, 1H, J = 1.8 Hz), 5.55 (dtt, 1H, J = 10.5, 6.9, 1.7 Hz), 
5.42 (dtt, 1H, J = 10.7, 7.3, 1.4 Hz), 5.31 (dtt, 1H, J = 10.5, 7.3, 1.7 Hz), 5.27 (dtt, 1H, 
J = 10.7, 7.2, 1.8 Hz), 4.09 (ddd, 1H, J = 9.1, 5.2, 3.6 Hz), 3.85 (dt, 1H, J = 8.5, 5.2 Hz), 2.86 
(ddqt, 1H, J = 7.0, 1.6, 2.5, 0.7 Hz), 2.64 – 2.59 (m, 2H), 2.48 – 2.37 (m, 2H), 1.92 (tq, 2H, 
J = 7.2, 2.6 Hz), 1.84 – 1.81 (m, 2H), 1.58 – 1.56 (m, 2H), 1.57 (t, 3H, J = 2.5 Hz), 1.56 (t, 
3H, J = 2.7 Hz), 1.35 – 1.31 (m, 2H), 1.20 – 1.16 (m, 2H), 0.68 ppm (t, 3H, J = 7.4 Hz); 
13
C NMR (150 MHz, C6D6):  = 180.4, 166.4, 164.4, 131.2, 128.5, 126.4, 125.7, 112.9, 92.1, 
82.7, 78.7, 77.3, 76.2, 76.0, 53.9, 32.3, 32.2, 28.4, 26.0, 25.8, 24.5, 18.7, 17.7, 9.1, 3.4, 
3.4 ppm; IR (film): ?̃? = 3359, 2920, 2851, 1661, 1632, 1578, 1411, 1247, 1086, 859, 800, 
700 cm
-1
; MS (pos. ESI) m/z (%): 495 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for 
C26H33O3BrNa [M
+
+Na]: 495.1506, found 495.1505. 
Compound anti-27. Activated MS 5 Å powder (70 mg) was added to a solution of anti-25 
(6.0 mg, 13 mol) in toluene (7 mL) and the resulting suspension was 
stirred for 0.5 h before a solution of the molybdenum alkylidyne complex 
26 (0.7 mg, 0.6 mol, 5 mol%)13 in toluene (0.05 mL) was introduced. 
After stirring for 2 h, the suspension was filtered through a pad of Celite, 
which was thoroughly rinsed with EtOAc. The combined filtrates were 
concentrated and the residued purified by flash chromatography (SiO2, 
EtOAc  EtOAc/acetone = 1:1) to remove Ph3SiOH. The material was further purified by 
preparative HPLC (UFLC SHIMADZU; Kromasil 100-5C18, 150 x 20 mm; 35 °C, 55 bar, 
20 mL/min, 240 nm, MeCN/H2O = 60/40) to yield the title compound as a colorless oil 
(4.4 mg, 80%). [𝛼]D
20 = −7.5 (c = 0.17, CHCl3). 
1
H NMR (600 MHz, C6D6):  = 5.88 (d, 1H, 
J = 1.8 Hz), 5.55 (d, 1H, J = 1.8 Hz), 5.48 (dtt, 1H, J = 10.3, 7.3, 1.7 Hz), 5.46 (dtt, 1H, 
J = 10.6, 7.1, 1.5 Hz), 5.37 (dtt, 1H, J = 10.6, 7.6, 1.7 Hz), 5.35 (dtt, 1H, J = 10.3, 7.1, 
1.4 Hz), 4.14 (td, 1H, J = 6.7, 4.0 Hz), 3.70 (ddd, 1H, J = 10.8, 5.0, 4.0 Hz), 2.79 – 2.76 (m, 
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4H), 2.58 – 2.53 (m, 1H), 2.50 – 2.45 (m, 1H), 1.93 (tt, 2H, J = 6.5, 2.3 Hz), 1.83 (ddd, 1H, 
J = 14.7, 9.2, 5.7 Hz), 1.74 – 1.69 (m, 1H), 1.61 – 1.54 (m, 1H), 1.49 – 1.43 (m, 2H), 1.39 – 
1.34 (m, 1H), 1.07 – 1.01 (m, 2H), 0.63 ppm (t, 3H, J = 7.8 Hz); 13C NMR (150 MHz, C6D6): 
 = 180.3, 166.4, 164.2, 131.0, 129.9, 125.8, 125.3, 113.2, 92.2, 83.0, 79.3, 79.2, 53.6, 32.6, 
31.9, 27.7, 26.2, 26.0, 24.6, 18.6, 17.3, 8.5 ppm; IR (film): ?̃? = 2922, 2852, 1663, 1630, 1584, 
1399, 1241, 1158, 928 cm
-1
; MS (pos. ESI) m/z (%): 443 (M+Na
+
, 100); HRMS (ESI): m/z: 
calcd. for C22H27O3BrNa [M
+
+Na]: 441.1037, found 441.1036. 
For an unambiguous assignment of the NMR data, see Table S-6 
Compound anti-1. N-Bromosuccinimide (1.3 mg, 7.3 µmol) was added in one portion to a 
solution of anti-27 (3.4 mg, 8.1 µmol) in THF (0.4 mL) at 0 °C. The 
colorless solution was stirred at ambient temperature and the reaction 
closely monitored by thin layer chromatography (pentane/EtOAc = 1:1). 
After complete consumption of the starting material, the mixture was 
diluted with pentane and filtered through a pad of Celite, which was 
carefully rinsed with pentane/EtOAc (1:1). The combined filtrates were 
concentrated and the residue purified by flash chromatography (SiO2, pentane/EtOAc = 1:1  
EtOAc 100%) to give the title compound (1.6 mg, 40%) as a colorless solid. [𝛼]D
20 = +18.0 
(c = 0.10, CHCl3). 
1
H NMR (600 MHz, CDCl3):  = 6.13 (s, 1H), 5.68 (dtt, 1H, J = 10.7, 7.4, 
1.6 Hz), 5.54 – 5.48 (m, 2H), 5.45 (dddt, 1H, J = 10.7, 8.0, 6.2, 1.7 Hz), 4.86 (td, 1H, J = 7.1, 
3.6 Hz), 4.15 (ddd, 1H, J = 9.1, 7.1, 4.8 Hz), 2.95 (ddt, 1H, J = 17.1, 6.5, 2.3 Hz), 2.91 – 2.87 
(m, 2H), 2.83 (ddt, 1H, J = 17.1, 5.9, 2.5 Hz), 2.77 (ddddt, 1H, J = 15.2, 6.1, 4.9, 1.8, 0.9 Hz), 
2.66 (dddd, 1H, J = 15.2, 9.1, 8.0, 1.4 Hz), 2.59 (ddd, 1H, J = 14.6, 9.3, 6.1 Hz), 2.51 (ddd, 
1H, J = 14.7, 9.3, 6.3 Hz), 2.27 – 2.24 (m, 2H), 2.06 (dq, 1H, J = 14.9, 7.4 Hz), 2.05 (ddq, 1H, 
J = 14.8, 3.7, 7.4 Hz), 1.86 – 1.75 (m, 2H), 1.58 – 1.55 (m, 2H), 1.07 ppm (t, 3H, J = 7.4 Hz); 
13
C NMR (150 MHz, CDCl3):  = 175.6, 163.3, 161.7, 131.1, 129.9, 125.6, 125.0, 111.7, 
92.3, 84.6, 79.2, 79.1, 53.8, 33.4, 33.0, 28.0, 26.6, 26.1, 25.6, 18.6, 17.1, 9.3 ppm; IR (film): 
?̃? = 2921, 2851, 1659, 1633, 1575, 1468, 1376, 1261, 1090, 800 cm-1; MS (pos. ESI) m/z (%): 
521 (M+Na
+
, 100); HRMS (ESI): m/z: calcd. for C22H26O3Br2Na [M
+
+Na]: 519.0140, found 
519.0141. 
For an unambiguous assignment of the NMR data and a comparison with those of the natural 











C data of bromide syn-15; 
numbering scheme as shown in the Insert. 
 
   
 1H NMR (C6D6, 600 MHz) 
13C NMR (C6D6, 150 MHz) 
No.   (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 0.81 3H t 2a, 2b 7.4 10.5 2a, 2b, 3 
2a 1.89 1H ddq 1, 2b, 3 13.6, 4.6, 7.5 
26.3 1, 3, 4 
2b 1.44 1H dq 1, 2a, 3 13.7, 7.5 
3 3.63 1H ddd 2a, 2b, 4 7.7, 4.6, 3.3 76.7 1, 2a, 2b, 4, 5a, 5b 
4 3.93 1H dt 3, 5a, 5b 10.1, 3.5  2a, 2b, 5a, 5b, 6 
5a 2.69 1H dddd 4, 5b, 6 15.5, 6.4, 3.6, 1.6 
31.7 3, 4, 6, 7 
5b 2.61 1H dddd 4, 5a, 6 15.2, 9.9, 7.5, 1.2 
6 5.53 1H dddt 5a, 5b, 7 10.7, 7.6, 6.2, 1.4 127.5 4, 5a, 5b, 7, 8a, 8b 
7 5.47 1H ddt 6, 8a, 8b 10.7, 7.0, 1.4 130.1 5a, 5b, 6, 8a, 8b, 9 
8a 2.78 1H dq 7, 8b, 9 16.0, 7.1 
26.1 6, 7, 9, 10, 11 
8b 2.75 1H dq 7, 8a, 9 16.0, 7.1 
9 5.39 1H dtt 8a, 8b, 10, 11 10.5, 7.2, 1.7 128.9 7, 8a, 8b, 10, 11 
10 5.56 1H dtt 9, 11 10.4, 7.0, 1.7 126.3 8a, 8b, 9, 11, 14 
11 2.90 2H ddqt 9, 10, 14 7.0, 1.9, 2.6, 0.7 17.7 8a, 8b, 9, 10, 14 
12 - - - - - 77.5 9, 10, 11, 14 
13 - - - - - 75.8 11, 14 
14 1.54 3H t 11 2.6 3.4 - 
15 - - - - - 18.3 16, 17, 18 
16 0.95 9H s - - 26.0 - 
17 0.00 3H s - - −4.2 18 









C data of syn-27; numbering scheme as 
shown in the Insert. 
 
   
 1H NMR (C6D6, 600 MHz) 
13C NMR (C6D6, 150 MHz) 
No.   (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 - - - - - 166.7 2, 20 
2 5.51 1H d 4 1.8 91.5 4 
3 - - - - - 180.3 2, 4 
4 5.87 1H d 2 1.8 113.1 2, 6a, 6b 
5 - - - - - 164.5 4, 6a, 6b 
6a 1.93 – 1.87 1H m 6b, 7 - 
32.6 4, 7, 8 
6b 1.67 1H dt 6a, 7 14.2, 7.8 
7 1.44 – 1.37 2H m 6a, 6b, 8 - 26.2 6a, 6b, 8, 9 
8 1.09 – 0.99 2H m 7, 9 - 27.6 6a, 6b, 7, 9 
9 1.90 – 1.87 2H m 8, 12a, 12b - 18.6 7, 8 
10 - - - - - 79.3 8, 9 
11 - - - - - 79.2 12a, 12b, 13, 14 
12a 2.83 1H dddt 9, 12b, 13 17.4, 8.0, 1.4, 2.1 
17.3 9, 13, 14 
12b 2.68 – 2.64 1H m 9, 12a, 13 - 
13 5.48 – 5.45 1H m 12a, 12b, 14 - 125.2 9, 12a, 12b, 14, 15a, 15b 
14 5.33 1H dtt 13, 15a, 15b 10.3, 6.9, 1.3 129.9 12a, 12b, 13, 15a, 15b 
15a 2.79 1H dt 14, 15b, 16 16.3, 7.4 
26.0 13, 14, 16, 17 
15b 2.73 1H dt 14, 15a, 16 16.3, 6.9 
16 5.46 – 5.42 1H m 15a, 15b, 17 - 131.0 14, 15a, 15b, 17, 18a, 18b 
17 5.20 1H dtt 15a, 15b, 16, 18a, 18b 10.7, 7.3, 1.7 126.0 15a, 15b, 16, 18a, 18b, 19 
18a 2.54 1H dddt 17, 19 15.1, 9.5, 7.2, 1.6 
33.1 16, 17, 19, 20 
18b 2.44 1H dddt 17, 19 15.1, 7.3, 4.9, 1.6 
19 3.63 1H ddd 18a, 18b, 20 9.5, 4.9, 2.6 54.4 17, 18a, 18b, 20, 21 
20 3.75 1H td 19, 21 6.8, 2.6 82.1 18a, 18b, 19, 21, 22 
21 1.65 – 1.55 2H m 20, 22 - 24.9 19, 20, 22 











C data of synthetic syn-1; numbering 
scheme as shown in the Insert. 
 
   
 1H NMR (CDCl3, 600 MHz) 
13C NMR (CDCl3, 150 MHz) 
No.   (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 - - - - - 162.0 20 
2 - - - - - 92.2 4 
3 - - - - - 175.8 4 
4 6.13 1H s - - 111.8 6a, 6b 
5 - - - - - 163.1 4, 6a, 6b, 7a, 7b 
6a 2.56 1H ddd 6b, 7a, 7b 14.7, 8.5, 6.4 
32.7 4, 7a, 7b, 8 
6b 2.53 1H ddd 6a, 7a, 7b 14.6, 8.4, 6.9 
7a 1.83 1H dtt 6a, 6b, 7b, 8 13.9, 8.5, 6.8 
26.4 4, 6a, 6b, 8, 9 
7b 1.79 1H dtt 6a, 6b, 7a, 8 13.7, 8.5, 6.8 
8 1.57 – 1.52 2H m 7a, 7b, 9 - 27.8 6a, 6b, 7a, 7b, 9 
9 2.26 – 2.24 2H m 8, 12 - 18.6 7a, 7b, 8 
10 - - - - - 79.2 8, 9, 12 
11 - - - - - 79.0 9, 12, 13 
12 2.91 – 2.88 2H m 9, 13 - 17.4 13, 14 
13 5.51 – 5.45 1H m 12 - 125.0 12, 15 
14 5.51 – 5.45 1H m 15 - 129.4 12, 15, 16 
15 2.90 – 2.78 2H m 14, 16, 17 - 26.1 13, 14, 16, 17 
16 5.67 1H dddt 15, 17, 18a, 18b 10.7, 7.6, 7.1, 1.4 130.8 14, 15, 17, 18a, 18b 
17 5.55 1H dtt 15, 16, 18a, 18b 10.7, 7.1, 1.6 125.9 15, 16, 18a, 18b, 19 
18a 2.73 1H dddd 16, 17, 18b, 19 15.1, 7.2, 5.4, 1.5 
33.6 16, 17, 19, 20 
18b 2.72 1H dddd 16, 17, 18a, 19 15.2, 8.3, 7.0, 1.5 
19 4.14 1H ddd 18a, 18b, 20 8.3, 5.5, 4.6 55.1 17, 18a, 18b, 21a, 21b 
20 4.90 1H ddd 19, 21a, 21b 7.4, 5.4, 4.6 84.6 18a, 18b, 19, 21a, 21b, 22 
21a 1.96 1H ddq 20, 22 14.3, 5.4, 7.5 
26.5 19, 20, 22 
21b 1.92 1H dq 20, 22 14.3, 7.3 
22 1.03 3H t 21a, 21b 7.4 9.7 20, 21a, 21b 
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C data of synthetic syn-1 with those of the natural product; numbering scheme as shown in the insert above. 
XX (C6D6)
4) Δ ((XX)-(lit.))
1H 13C 1H 13C Δ 1H Δ 13C 1H Δ 1H
5 1 – 161,6 – 162,0 – 0,4 – –
2 2 – 91,8 – 92,2 – 0,4 – –
3 3 – 175,4 – 175,8 – 0,4 – –
4 4 6,10 111,2 6,13 111,8 0,03 0,6 5,80 -0,30





8 8 1,60 27,5 1,55 27,8 -0,05 0,3 1,00 -0,60
12 9 2,22 18,2 2,25 18,6 0,03 0,4 1,91 -0,31
10 10 – 78,8 – 79,2 – 0,4 – –
11 11 – 78,5 – 79,0 – 0,5 – –
21 12 2,88 17,0 2,90 17,4 0,02 0,4 2,71 -0,17
14 13 5,40 124,6 5,47 125,0 0,07 0,4 5,31 -0,09
17 14 5,40 128,9 5,47 129,4 0,07 0,5 5,39 -0,01
15 15 2,88 25,7 2,85 26,1 -0,03 0,4 2,61 -0,27
13 16 5,40 130,3 5,67 130,8 0,27 0,5 5,47 0,07
16 17 5,40 125,5 5,55 125,9 0,15 0,4 5,47 0,07
2,73 0,01
2,72 0,00
19 19 4,14 54,9 4,14 55,1 0,00 0,2 3,81 -0,33
20 20 4,90 84,2 4,80 84,6 -0,10 0,4 4,47 -0,43
1,96 0,04
1,92 0,00
22 22 1,00 9,3 1,03 9,7 0,03 0,4 0,69 -0,31
1) 1H and 13C NMR shifts were reassigned according to 2D experiments .
2)
 Source of data: R. Kazlauskas, P. T. Murphy, R. J. Wells, A. J. Blackman, Aust. J. Chem . 1982, 35 , 113. 
3) Experiments were run on a 600 MHz/150 MHz NMR machine accordingly, 298 K.
4)
 For comparison a 
1















7 1,88 26,1 26,4 0,3
12 1,92 26,1
18 6 2,58 32,3
26,5 0,4








C data of anti-15; numbering 
scheme as shown in the Insert. 
 
   
 1H NMR (C6D6, 600 MHz) 
13C NMR (C6D6, 150 MHz) 
No.   (ppm) Integral Splitting COSY J (Hz)  (ppm) HMBC 
1 0.82 3H t 2a, 2b 7.5 9.1 2a, 2b, 3 
2a 1.80 1H ddq 1, 2b, 3 14.0, 6.2, 7.4 
27.5 1, 3, 4 
2b 1.43 1H ddq 1, 2a, 3 14.0, 4.6, 7.4 
3 3.72 1H dt 2a, 2b, 4 6.2, 4.7 76.7 1, 2a, 2b, 4 
4 3.95 1H ddd 3, 5a, 5b 9.5, 4.7, 4.3 59.5 2a, 2b, 5a, 5b, 6 
5a 2.68 1H dddd 4, 5b, 6 15.3, 6.8, 4.2, 1.3 
32.3 3, 4, 6, 7 
5b 2.56 1H dddd 4, 5a, 6 15.5, 9.5, 6.8, 1.2 
6 5.51 1H dtt 5a, 5b, 7 10.7, 6.7, 1.4 127.4 4, 5a, 5b, 7, 8 
7 5.46 1H dtt 6, 8 10.7, 7.0, 1.3 130.0 5a, 5b, 6, 8, 9 
8 2.76 – 2.73 2H m 7, 9 - 26.0 7, 9, 10, 11 
9 5.39 1H dtt 8, 10, 11 10.5, 7.3, 1.7 128.9 7, 8, 10, 11 
10 5.56 1H dtt 9, 11 10.5, 7.1, 1.7 126.3 8, 9, 11 
11 2.88 2H ddqt 9, 10, 14 7.0, 1.8, 2.6, 0.8 17.7 8, 9, 10, 14 
12 - - - - - 77.5 9, 10, 11, 14 
13 - - - - - 75.8 11, 14 
14 1.54 3H t 11 2.6 3.4 - 
15 - - - - - 18.4 16, 17, 18 
16 0.99 9H s - - 26.1 - 
17 0.10 3H s - - −4.2 18 









C data of anti-27; numbering scheme as 
shown in the Insert. 
 
   
 1H NMR (C6D6, 600 MHz) 
13C NMR (C6D6, 150 MHz) 




1 - - - - - 166.4 2, 20 
2 5.55 1H d 4 1.8 92.2 4 
3 - - - - - 180.3 2, 4 
4 5.88 1H d 2 1.8 113.2 2, 6a, 6b 
5 - - - - - 164.2 4, 6a, 6b 
6a 1.83 1H ddd 6b, 7 14.7, 9.2, 5.7 
31.9 4, 7, 8 
6b 1.74 – 1.69 1H m 6a, 7 - 
7a 1.49 – 1.43 1H m 6a, 6b, 8 - 
26.2 6a, 6b, 8, 9 
7b 1.39 – 1-43 1H m   
8 1.07 – 1.01 2H m 7, 9 - 27.7 6a, 6b, 7, 9 
9 1.93 2H tt 8, 12a, 12b 6.5, 2.3 18.6 7, 8 
10 - - - - - 79.3 8, 9 
11 - - - - - 79.2 12a, 12b, 13, 14 
12 2.79 – 2.76 2H m 9, 12b, 13 - 17.3 9, 13, 14 
13 5.48 1H dtt 12a, 12b, 14 10.3, 7.3, 1.7 125.3 9, 12a, 12b, 14, 15a, 15b 
14 5.35 1H dtt 13, 15a, 15b 10.3, 7.1, 1.4 129.9 12a, 12b, 13, 15a, 15b 
15 2.79 – 2.76 2H m 14, 15b, 16 - 26.0 13, 14, 16, 17 
16 5.37 1H dtt 15a, 15b, 17 10.6, 7.6, 1.7 131.0 14, 15a, 15b, 17, 18a, 18b 
17 5.46 1H dtt 15a, 15b, 16, 18a, 18b 10.6, 7.1, 1.5 125.8 15a, 15b, 16, 18a, 18b, 19 
18a 2.58 – 2.53 1H m 17, 19 - 
32.6 16, 17, 19, 20 
18b 2.50 – 2.45 1H m 17, 19 - 
19 3.70 1H ddd 18a, 18b, 20 10.8, 5.0, 4.0 53.6 17, 18a, 18b, 20, 21 
20 4.14 1H td 19, 21 6.7, 4.0 83.0 18a, 18b, 19, 21, 22 
21a 1.61 – 1.54 1H m 20, 22 - 
24.6 19, 20, 22 
21b 1.49 – 1.43 1H m 20, 22 - 









C data of anti-1; numbering scheme as 
shown in the Insert. 
 
   
 1H NMR (CDCl3, 600 MHz) 
13C NMR (CDCl3, 150 MHz) 




1 - - - - - 161.7 20 
2 - - - - - 92.3 4 
3 - - - - - 175.6 4 
4 6.13 1H s - - 111.7 6a, 6b 
5 - - - - - 163.3 4, 6a, 6b, 7 
6a 2.59 1H ddd 6b, 7 14.6, 9.3, 6.1 
33.0 4, 7, 8 
6b 2.51 1H ddd 6a, 7 14.7, 9.3, 6.3 
7 1.86 – 1.75 2H m 6a, 6b, 8 - 26.6 6a, 6b, 8, 9 
8 1.58 – 1.55 2H m 7, 9 - 28.0 6a, 6b, 7, 9 
9 2.27 – 2.24 2H m 8, 12 - 18.6 7, 8 
10 - - - - - 79.2 8, 9, 12 
11 - - - - - 79.1 9, 12 
12a 2.95 1H ddt 9, 12b, 13 17.1, 6.5, 2.3 
17.1 13, 14 
12b 2.83 1H ddt 9, 12a, 13 17.1, 5.9, 2.5 
13 5.54 – 5.48 1H m 12a, 12b - 125.0 12a, 12b, 15 
14 5.54 – 5.48 1H m 15 - 129.9 13, 15 
15 2.91 – 2.87 2H m 14, 16 - 26.1 13, 14, 17 
16 5.68 1H dtt 15, 17 10.7, 7.4, 1.6 131.1 13, 15, 18a, 18b 
17 5.45 1H dddt 16, 18a, 18b 10.7, 8.0, 6.2, 1.7 125.6 15, 18a, 18b, 19 
18a 2.77 1H ddddt 17, 18b, 19 
15.2, 6.1, 4.9, 1.8, 
0.9 33.4 16, 17, 20 
18b 2.66 1H dddd 17, 18a, 19 15.2, 9.1, 8.0, 1.4 
19 4.15 1H ddd 18a, 18b, 20 9.1, 7.1, 4.8 55.8 18a, 18b, 21a, 21b 
20 4.86 1H td 19, 21a, 21b 7.1, 3.6 84.6 18a, 18b, 19, 21a, 21b, 22 
21a 2.06 1H dq 20, 22 14.9, 7.4 
25.6 19, 20, 22 
21b 2.05 1H ddq 20, 22 14.8, 3.7, 7.4 
22 1.05 3H t 21a, 21b 7.4 9.3 20, 21a, 21b 
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5 1 – 161,6 – 161,7 – 0,1
2 2 – 91,8 – 92,3 – 0,5
3 3 – 175,4 – 175,6 – 0,2
4 4 6,10 111,2 6,13 111,7 0,03 0,5





8 8 1,60 27,5 1,56 28,0 -0,04 0,5
12 9 2,22 18,2 2,26 18,6 0,04 0,4
10 10 – 78,8 – 79,2 – 0,4
11 11 – 78,5 – 79,1 – 0,6
21 12 2,88 17,0 2,95 17,1 0,07 0,1
14 13 5,40 124,6 5,51 125,0 0,11 0,4
17 14 5,40 128,9 5,51 129,9 0,11 1,0
15 15 2,88 25,7 2,89 26,1 0,01 0,4
13 16 5,40 130,3 5,68 131,1 0,28 0,8
16 17 5,40 125,5 5,45 125,6 0,05 0,1
2,77 0,05
2,66 -0,06
19 19 4,14 54,9 4,15 55,8 0,01 0,9
20 20 4,90 84,2 4,86 84,6 -0,04 0,4
2,06 0,14
2,05 0,13
22 22 1,00 9,3 1,05 9,7 0,05 0,4
1) 1H and 13C NMR shifts were reassigned according to 2D experiments .
2)
 Source of data: R. Kazlauskas, P. T. Murphy, R. J. Wells, A. J. Blackman, Aust. J. Chem . 1982, 35 , 113. 
3) Experiments were run on a 600 MHz NMR machine, 298 K.
-0,5
# (reassigned)*# (lit.)
natural XX (CDCl3)* synthetic XX (anti, CDCl3) Δ ((XX)-(lit.))
12 21 1,92 26,1 25,6
0,5
6 18 2,72 33,2 33,4 0,2
7 7 1,88 26,1 26,6
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